RT Journal Article
SR Electronic
T1 Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.05.20054163
DO 10.1101/2020.04.05.20054163
A1 Martha K. Berg
A1 Qinggang Yu
A1 Cristina E. Salvador
A1 Irene Melani
A1 Shinobu Kitayama
YR 2020
UL http://medrxiv.org/content/early/2020/05/28/2020.04.05.20054163.abstract
AB BCG vaccination may reduce the risk of a range of infectious diseases, and, if so, could serve as a protective factor against COVID-19. Here, we compared countries that mandated BCG vaccination at least until 2000 with to countries that did not (139 countries in total). To minimize any systematic effects of reporting biases, we analyzed the rate of the day-by-day increase in both confirmed cases and deaths in the first 30-day period of country-wise outbreaks. The 30-day window was adjusted to begin at the country-wise onset of the pandemic. Linear mixed models revealed a significant effect of mandated BCG policies on the growth rate of both cases and deaths after controlling for median age, gross domestic product per capita, population density, population size, net migration rate, and various cultural dimensions (e.g., individualism and the tightness vs. looseness of social norms). Our analysis suggests that mandated BCG vaccination can be effective in the fight against COVID-19.Teaser National policies for universal BCG vaccination are associated with flattened growth of country-wise COVID-19 cases and deaths.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the public domain.